An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.

This study highlights the significance of developing specialized prognostication approaches and investigating effective therapeutic drugs for patients with CRLM. The application of a deep learning drug response model provides a new drug discovery strategy for translational medicine in precision oncology.